Nanalysis Scientific (NSCI) Q4 2024 (Q&A) earnings summary

Executive summary

• Achieved record quarterly revenue of $12.3 million in Q4 2024, up 25% year-over-year, and record annual revenue of $45 million, up 60% from 2023, with all business segments showing simultaneous progress for the first time.

• Adjusted EBITDA reached $1.8 million in Q4 and $2.8 million for the full year, both significant improvements over prior periods.

• Achieved positive gross margins and improved operational efficiency after significant investments in a major contract.

• Revenue growth driven by expansion in both product sales and security services, with operational efficiencies improving margins.

• Focus remains on significant revenue growth and expanding profit margins over the next five years.

Financial highlights

• Q4 2024 gross margin on product sales was 60%, up from 48% in Q4 2023; service revenue margin improved to 16% from -27%.

• Full-year 2024 gross margin on product sales was 53% (up from 41% in 2023); service revenue margin was 12% (up from -29%).

• Normalized net loss for Q4 was $400, a significant improvement from $2,123 in Q4 2023; full-year normalized net loss was $6,287, improved from $13,974 in 2023.

• Positive operating cash flow of $1.1 million in Q4 and $3.3 million for the year, compared to negative cash flow in 2023.

• Investments in R&D and capital assets totaled about CAD 1.7 million, with operational cash flow exceeding internal investment needs.

Outlook and guidance

• Expects continued revenue growth in security services and ongoing improvement in gross margins through 2025.

• Anticipates some downward pressure on product sales in H1 2025 due to global tariff uncertainties, but mitigation efforts are in place.

• Focus remains on growing Benchtop NMR sales, expanding margins, and generating positive free cash flow.

• Plans to maintain strong investment in R&D and product development, ensuring ongoing innovation.

• Ongoing cost efficiency improvements are expected to not impact revenue growth or innovation.